{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "PARK7 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PARK7 DJ-1 have been associated with autosomal-recessive early-onset Parkinson's disease (PD). The gene encodes a redox-dependent chaperone, and proteasome impairment induces apoptosis in PD.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links DJ-1 dysfunction to proteasome impairment and apoptosis, key mechanisms in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Yeast two-hybrid screening identified TTRAP as a DJ-1 interactor. Cell-based assays demonstrated TTRAP's protective role against proteasome-induced apoptosis.",
          "judgment": "Yes",
          "reasoning": "Protein interaction assays and apoptosis models directly address the disease mechanism of proteasome dysfunction and cell death in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type DJ-1 and mutants (M26I, L166P) were compared in yeast two-hybrid and cell-based assays. No explicit statement on replicates.",
          "judgment": "No",
          "reasoning": "While controls (wild-type vs. mutants) were used, the paper does not confirm multiple replicates or independent experiments."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "3b: Accepted/Validated Assay",
          "extracted_paper_info": "Yeast two-hybrid is a standard method for protein interaction studies. Cell-based apoptosis assays model proteasome impairment in PD.",
          "judgment": "Yes",
          "reasoning": "The assays are widely accepted in the field for studying protein interactions and apoptosis mechanisms.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step": "4a: Statistical Analyses",
          "extracted_paper_info": "No statistical tests or OddsPath calculations are explicitly reported for the M26I variant.",
          "judgment": "No",
          "reasoning": "The paper lacks statistical validation or quantitative pathogenicity metrics."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step": "4b: No OddsPath Calculation",
          "extracted_paper_info": "Two variants (M26I and L166P) were tested as controls against wild-type DJ-1.",
          "judgment": "Yes",
          "reasoning": "Only two control variants were used, which is ≤10 total, limiting statistical strength.",
          "next_step_or_outcome": "PS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "PARK7 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PARK7 DJ-1 have been associated with autosomal-recessive early-onset Parkinson's disease (PD). The gene encodes a redox-dependent chaperone, and proteasome impairment induces apoptosis in PD.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links DJ-1 dysfunction to proteasome impairment and apoptosis, key mechanisms in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Yeast two-hybrid screening identified TTRAP as a DJ-1 interactor. Cell-based assays demonstrated TTRAP's protective role against proteasome-induced apoptosis.",
          "judgment": "Yes",
          "reasoning": "Protein interaction assays and apoptosis models directly address the disease mechanism of proteasome dysfunction and cell death in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type DJ-1 and mutants (M26I, L166P) were compared in yeast two-hybrid and cell-based assays. No explicit statement on replicates.",
          "judgment": "No",
          "reasoning": "While controls (wild-type vs. mutants) were used, the paper does not confirm multiple replicates or independent experiments."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_step": "3b: Accepted/Validated Assay",
          "extracted_paper_info": "Yeast two-hybrid is a standard method for protein interaction studies. Cell-based apoptosis assays model proteasome impairment in PD.",
          "judgment": "Yes",
          "reasoning": "The assays are widely accepted in the field for studying protein interactions and apoptosis mechanisms.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step": "4a: Statistical Analyses",
          "extracted_paper_info": "No statistical tests or OddsPath calculations are explicitly reported for the L166P variant.",
          "judgment": "No",
          "reasoning": "The paper lacks statistical validation or quantitative pathogenicity metrics."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step": "4b: No OddsPath Calculation",
          "extracted_paper_info": "Two variants (M26I and L166P) were tested as controls against wild-type DJ-1.",
          "judgment": "Yes",
          "reasoning": "Only two control variants were used, which is ≤10 total, limiting statistical strength.",
          "next_step_or_outcome": "PS3_supporting"
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    }
  ]
}